Due to their unstable genomes, these cells produce particular cytoplasmic DNA fragments (at baseline or under chemotherapeutic treatments) which sense the cGAS/STING and type I IFN signaling pathways to induce the production of CXCL10 and CCL5 and the recruitment of CD8 T cells at the tumor site. The gene discussed is STING1; the disease is neoplasm.